Introduction To the Fluoroquinolone Lawsuit
Fluoroquinolone Lawsuits: Involve claims that manufacturers of antibiotic drugs like Cipro, Levaquin and Avelox failed to adequately warn patients and doctors about severe, permanent side effects.
Key Allegations and Fluoroquinolone Adverse Events
Peripheral Neuropathy: Plaintiffs claim the drugs cause irreversible, painful nerve damage in the hands and feet, and that drug makers knew of these risks years before the FDA strengthened warning labels.
- Aortic Aneurysm and Dissection: Studies and FDA warnings indicated that fluoroquinolones can double the risk of dangerous tears or bulges in the body’s main artery.
- Tendon Ruptures: Early lawsuits focused on severe tendinitis and Achilles tendon tears, prompting a black box warning from the FDA in 2008
- The FDA Warning: In 2008, the S. Food and Drug Administration (FDA) ordered manufacturers of fluoroquinolones to add a Boxed Warning (the agency’s strongest warning) regarding the increased risk of tendinitis and tendon rupture.
- Who is at Risk? While it can happen to anyone, the risk is significantly higher for patients over 60, those taking concomitant corticosteroid drugs, and kidney, heart, or lung transplant recipients.
- Expanded Warnings: Since 2008, the FDA has further updated warnings for these drugs to include potential permanent side effects involving the central nervous system, peripheral neuropathy (nerve damage), and aortic aneurysms.
Current Status of Fluoroquinolone lawsuits
- Multidistrict Litigation (MDL): Most federal cases involving peripheral neuropathy were centralized in an MDL in Minnesota federal court (MDL No. 2642), which has resolved the vast majority of claims through confidential settlements.
- Availability of Counsel: Because the primary wave of litigation has largely concluded and most active claims have been settled or dismissed, most law firms are no longer actively accepting new fluoroquinolone cases.
Key FDA Timeline & Warnings Concerning Fluoroquinolone Adverse Events
- July 2008: Added a black box warning for an increased risk of tendinitis and tendon rupture.
- August 2013: Required label updates warning that peripheral neuropathy (nerve damage in the arms or legs) can occur rapidly, last for months or years, or be permanent.
- July 2016: Strengthened warnings regarding disabling side effects involving the central nervous system, muscles, joints, and tendons, restricting use for certain uncomplicated infections.
- July 2018: Warned of significantly low blood sugar (hypoglycemia) and psychiatric adverse effects.
- December 2018: Updated warnings to include an increased risk of aortic aneurysms and dissections (tears or ruptures in the body’s main artery), advising against use in high-risk patients unless no alternatives exist.
Fluoroquinolone High Risk Symptoms
- Vulnerable Patients: Elderly individuals and those with high blood pressure, genetic blood-vessel disorders (like Marfan or Ehlers-Danlos syndrome), or a history of blockages/aneurysms should avoid these drugs when possible.
- When to Seek Help: Get emergency medical care immediately if you experience sudden, severe, and constant chest, stomach, or back pain, or signs of nerve damage like burning, tingling, or numbness
If you or a loved one took Fluoroquinolone and subsequently suffered severe adverse health effects, contact Fluoroquinolone lawsuit lawyer, Timothy L. Miles today for a free case evaluation. You could meet the criteria for a Fluoroquinolone lawsuit and potentially be entitled to substantial compensation in a Fluoroquinolone lawsuit.
What is Fluoroquinolone?
AI Overview
- Fluoroquinolones are indeed a highly potent class of broad-spectrum antibiotics, though their annual use in the United States has declined from historical highs due to updated safety guidelines.
- FDA Safety Alerts: While they were historically among the most frequently prescribed antibiotics—with tens of millions of prescriptions written annually—the FDA issued a series of strong safety alerts beginning in 2016.
- Serious Risks of Fluoroquinolones : These warnings explicitly advised that the serious risks of fluoroquinolones outweigh their benefits for common, uncomplicated ailments like simple urinary tract infections (UTIs), acute sinusitis, and bronchitis.
Mechanism of Action
- Inhibit Bacterial DNA Replication: Unlike antibiotics that target bacterial cell walls, fluoroquinolones act directly on the genetic machinery of the bacteria. They work by inhibiting bacterial topoisomerase IV and DNA gyrase.
- Districting Cell Division: two enzymes are vital for bacterial DNA replication and cell division. By disrupting this process, they prevent the bacteria from multiplying, effectively killing the infection.
Common Fluoroquinolones
Medications in this class are easily recognized by the generic suffix “-floxacin”. Common examples include:
- Ciprofloxacin (Cipro)
- Levofloxacin (Levaquin)
- Moxifloxacin (Avelox)
Levaquin
Levaquin was first approved for marketing in 1996 .It accounts for around 28% of all fluoroquinolone prescriptions in the United States, making it the second most popular fluoroquinolone antibiotic.
It was previously the most prescribed antibiotic in 2010, used to treat a range of bacterial infections including:
- Urinary tract infections
- Respiratory infections
- Bronchitis
- Pneumonia
- And even plague
FDA Says New Warning Appropriate: According to the FDA, a new warning is needed for Levaquin, Cipro, Avelox and other fluoroquinolones (FQs).
Serious Multi-Symptom Side Effects: This warning is needed because they may trigger a serious, persistent, multi-symptom disability referred to as fluoroquinolones-associated disability (FQAD).
FQAD: Refers to a “constellation of symptoms” leading to disability that has been observed during FDA monitoring of FQ safety reports.
No-Prior Warning: Although most of the individual symptoms observed are documented in literature and reflected in the FQ drug medication guides, there have been no warnings in the past about a link to a constellation of symptoms across organ systems.
Test for Fluoroquinolone Associated Disability
According to the FD), an official operational diagnosis of Fluoroquinolone-Associated Disability (FQAD) requires an individual to meet the following three (3) criteria:
- Disability: The adverse effects must cause a substantial disruption of the person’s ability to conduct normal life functions.
- Multi-System Involvement: The individual must experience adverse events reported from two (2) or more of the following body systems:
- Musculoskeletal (e.g., tendinitis, tendon rupture, joint pain)
- Neuropsychiatric (e.g., anxiety, insomnia, severe fatigue, depression)
- Peripheral nervous system (e.g., peripheral neuropathy, numbness, tingling)
- Senses (e.g., vision changes, tinnitus)
- Skin (e.g., rash, hair loss)
- Cardiovascular (e.g., palpitations, chest pain)
- Persistence: The reported adverse events must last 30 days or longer after stopping the fluoroquinolone antibiotic
Fluoroquinolones Linked to Adverse Side Effects
The FDA has discovered links between fluoroquinolone antibiotics and a number of adverse, disabling and potentially irreversible health risks.
These irreversible health risks include:
- Tendon injuries
- Muscle injuries
- Joint injuries
- Injuries to the nerves and the central nervous system.
In addition, these can also cause a range of side effects, including:
- Tendon damage or rupture
- Permanent nerve damage in the extremities
- Liver toxicity
- Kidney failure
- Hearing or vision problems
- Psychiatric side effects
Many of these symptoms can be irreversible.
Because of the dangerous health risks involved with fluoroquinolones, the FDA recommends that for some more common bacterial infections fluoroquinolones only be used if no other options are viable.
Evidence to Gather for Fluoroquinolone lawsuit
- Treatment records
- Witness Statements and/or accounts
- Proof that you took Fluoroquinolone medication
- Photos and videos of injuries
- Any other proof of Fluoroquinolone use caused subsequent medical problems
- Witnesses that saw the pain and suffering caused by the Fluoroquinolone use
Compensation in a Fluoroquinolone lawsuit
If you meet the criteria for a Fluoroquinolone lawsuit, potential damages may include:
- Medical bills
- Future medical expenses and medical costs
- Pain and suffering
- Emotional distress
- Lost quality of life
- Lost wages and earning ability
- Permanent damage resulting in disability
- Other compensatory and punitive damages
Do You Qualify for a Fluoroquinolone lawsuit?
- If you or a loved one took Fluoroquinolone and subsequently:
- Suffered severe adverse health effects,
- Contact Fluoroquinolone lawsuit lawyer, Timothy L. Miles today for a free case evaluation.
- Eligible for Lawsuit: You could meet the criteria for a Fluoroquinolone lawsuit and potentially be entitled to substantial compensation in a Fluoroquinolone lawsuit.
Contact a Fluoroquinolone Lawsuit Lawyer Timothy L. Miles Today for a Free Case Evaluation
If you or a loved one took Fluoroquinolone and subsequently suffered severe adverse health effects, contact Fluoroquinolone lawsuit lawyer, Timothy L. Miles today for a free case evaluation. You could meet the criteria for a Fluoroquinolone lawsuit and potentially be entitled to substantial compensation in a Fluoroquinolone lawsuit.
Timothy L. Miles, Esq.
Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr. #247
Mailbox #1091
Brentwood,TN 37027
Phone: (855) Tim-MLaw (855-846-6529)
Email: [email protected]
Website: www.classactionlawyertn.com
Facebook Linkedin Pinterest youtube